Novo Nordisk's new CEO said he was confident in the company's pipeline of obesity drugs, but that buying Metsera would allow it to expand its options ...
In April, Danish drugmaker Novo Nordisk formed what was supposed to be a long-term collaboration to promote its weight-loss drug Wegovy on the popular telehealth service Hims & Hers. The deal was Novo ...
Hosted on MSN
Novo Nordisk stock plunges 23% after cutting sales forecast and naming Mike Doustdar as new CEO
NVO stock: Novo Nordisk stock dropped more than 23% on Tuesday morning after the pharmaceutical giant cut its full-year sales forecast and named a new CEO, as per a CNBC report. This unsettled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback